Ascendis Pharma AS Cash Flow-to-Debt Ratio
Ascendis Pharma AS cash flow-to-debt ratio. Ascendis Pharma AS (A71) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of €-7.72 Million could theoretically repay 0% of its total liabilities (€1.52 Billion) in one year. Check earnings quality score of Ascendis Pharma AS to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ascendis Pharma AS (2016–2025)
Cash flow-to-debt ratio of Ascendis Pharma AS from 2016 to 2025. Historical debt coverage capacity for Ascendis Pharma AS across 10 annual periods. Check Ascendis Pharma AS (A71) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Ascendis Pharma AS Cash Flow-to-Debt Ratio by Year (2016–2025)
Ascendis Pharma AS cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Ascendis Pharma AS. For the full cash flow conversion analysis, see Ascendis Pharma AS cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | €53.90 Million | €1.47 Billion | ▲ +115.4% |
| 2024 | -0.24x | €-306.20 Million | €1.29 Billion | ▲ +50.5% |
| 2023 | -0.48x | €-467.36 Million | €971.28 Million | ▲ +19.8% |
| 2022 | -0.60x | €-495.70 Million | €826.39 Million | ▲ +71.1% |
| 2021 | -2.07x | €-417.65 Million | €201.29 Million | ▼ -7.8% |
| 2020 | -1.92x | €-271.55 Million | €141.08 Million | ▲ +12.9% |
| 2019 | -2.21x | €-175.94 Million | €79.62 Million | ▲ +38.0% |
| 2018 | -3.57x | €-138.80 Million | €38.92 Million | ▲ +10.9% |
| 2017 | -4.00x | €-95.10 Million | €23.77 Million | ▲ +10.5% |
| 2016 | -4.47x | €-60.18 Million | €13.46 Million | — |